Unclassified Vitiligo

Unclassified vitiligo presents as an early disease and is begins as a focal condition that progresses to multifocal asymmetrical non-segmental and/or unifocal mucosal vitiligo.

 

What is Unclassified Vitiligo?

During the early phases of vitiligo, when symptoms are still developing, the unclassified description is utilized. Symptoms and signs vitiligo typically begins as a few little white patches that expand over several months. It can affect any region of the body, although the hands, feet, forearms, and face are the most commonly affected.

Signs and Symptoms of Unclassified Vitiligo

Symptoms of unclassified vitiligo include:

  • Skin discoloration that develops in patches on the hands, face, and around bodily openings and the genitals.
  • Hair on your scalp, eyelashes, eyebrows, or beard that is prematurely whitening or graying
  • The tissues that line the interior of your mouth and nose have lost their color (mucous membranes)

Vitiligo can arise at any age, however it is more common before the age of 30.

Treating Unclassified Vitiligo

Topical corticosteroids (TCS) and topical calcineurin inhibitors (TCI) are used to treat unclassified vitiligo (such as tacrolimus and pimecrolimus). Topical administration of 0.1 percent 8-methoxypsoralen or other psoralen-containing topical formulations, as well as topical vitamin D3 derivatives, are all possibilities. 308 nm excimer laser therapy, monochromatic excimer light (MEL) therapy, and narrowband ultraviolet B (NB-UVB) therapy are the favored therapies for unclassified vitiligo. In situations of rapid advancement, systemic corticosteroids should be given because early management can stop vitiligo from spreading.

Join Our Vitiligo Community

Are you dealing with a recent diagnosis or know someone who has vitiligo? We’re here to help you figure out what works best to manage symptoms and improve overall day-to-day life whether you or someone you love is affected.

Stay up-to-date on the latest news about treatments and managing symptoms. Sign up to get important email updates with relevant information.

This field is for validation purposes and should be left unchanged.